Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,228 | 83,507 | 108,087 | 81,394 | 114,637 |
| Marketable Securities | 181,299 | 222,709 | 230,988 | 247,346 | 283,996 |
| Receivables | 32,684 | 31,952 | 27,549 | 23,200 | 22,439 |
| Inventories | 21,098 | 21,210 | 27,105 | 25,343 | 25,528 |
| TOTAL | $349,937 | $381,096 | $417,576 | $405,050 | $476,159 |
| Non-Current Assets | |||||
| PPE Net | 5,155 | 5,421 | 5,864 | 6,213 | 6,511 |
| Investments And Advances | 26,778 | 46,699 | 41,187 | 64,022 | 30,904 |
| Other Non-Current Assets | 39,058 | 40,350 | 33,209 | 34,333 | 35,445 |
| TOTAL | $70,991 | $92,470 | $80,260 | $104,568 | $72,860 |
| Total Assets | $420,928 | $473,566 | $497,836 | $509,618 | $549,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,459 | 26,476 | 21,453 | 18,211 | 19,670 |
| Accrued Expenses | 60,396 | 70,295 | 68,005 | 59,455 | 60,942 |
| TOTAL | $83,429 | $100,275 | $92,894 | $81,034 | $83,913 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,449 | 22,375 | 23,272 | 24,154 | 25,022 |
| TOTAL | $21,449 | $22,375 | $23,272 | $24,154 | $25,022 |
| Total Liabilities | $104,878 | $122,650 | $116,166 | $105,188 | $108,935 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,476 | 80,800 | 80,123 | 78,821 | 78,525 |
| Common Shares | 821 | 805 | 799 | 788 | 785 |
| Retained earnings | -1,473,388 | -1,428,305 | -1,381,115 | -1,331,534 | -1,282,972 |
| Other shareholders' equity | 98 | 577 | -896 | -967 | -181 |
| TOTAL | $316,050 | $350,916 | $381,670 | $404,430 | $440,084 |
| Total Liabilities And Equity | $420,928 | $473,566 | $497,836 | $509,618 | $549,019 |